Immunocore

IPO

Pioneers of the world's first approved TCR therapy

Immunocore was founded in 2008, is headquartered in Abingdon, Oxon, United Kingdom, lists 201–500 employees, and has $205.0M in recorded funding across 2 rounds.

Headquarters
Abingdon, Oxon
Employees
201–500
Founded
2008
Business Model
B2B
Total Funding
$205.0M
Last Round
$75.0M Series CJan 2021
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Immunocore is a commercial-stage biotechnology company that discovered, developed, and commercialized the world's first approved T cell receptor (TCR) therapy, built on its proprietary ImmTAX platform derived from University of Oxford research. The modular platform underpins a pipeline of bispecific immunotherapies spanning oncology, HIV, and HBV, plus autoimmune disease, with partnerships including Genentech, GSK, and the Bill & Melinda Gates Foundation.

Summary

Immunocore is a Healthcare company based in Abingdon, Oxon, United Kingdom, founded in 2008. It lists 201–500 employees. It has raised $205.0M in total across 2 rounds, most recently a $75.0M Series C round in Jan 2021. Investors include Omega Funds and General Atlantic.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOFeb 2021
$297.1M

Sign up to see all 3 events

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
PHC

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...

Minato, Japan5001–10000Healthcare, Life Sciences
Private EquityTotal funding$1.9BMar 2021
Oscar HealthIPO

Oscar Health uses technology to deliver simple, personalized health insurance and member-care exp...

New York, United States1001–5000Healthcare, Insurance
ConvertibleTotal funding$1.8BOct 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Immunocore on Indexed.vc
<a href="https://indexed.vc/companies/immunocore"><img src="https://indexed.vc/api/badge/company/immunocore" alt="Immunocore on Indexed.vc" width="260" height="76" /></a>